Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Post by SouthernTierTomon Apr 04, 2022 7:58am
160 Views
Post# 34572266

Fore IR inputs? Fore existing FDA approvals?...

Fore IR inputs? Fore existing FDA approvals?...20 years of Stockhouse social media management?

Hmmmm... how important is "Precision Medicine" as it pertains to the "Personalized removal of endotoxin in a critical care setting"

"Lessons Learned", now that we know the capacity of the PMX filter AND can identify the correct patient at the precise time.. maybe duplication of the 2009 results from phase 2 Euphas... WHO knows... maybe better?

"Blair's welcome bonus" check SEDI for details...

still no registration of the "opening amount" ... Today is day one for our new CFO - Welcome!!!

Based on recent trading activity, a WHOPPING 1/2 of 1% of the float trading for ALL of March ... along with closing SP placement, it would seem the tremendous knew addition will likely achieve the Feb.28 2022 magical number of .32 CAD - "FARE INDEED" ; - )

Things sure have changed in the last few years...

Our most seasoned addition to the CFO role a few years back received 75,000 options for his arrival from the Windy City.

Next up was the arrival from the nano-cap "pot play" ( NOW DE-LISTED ), for an unknown reason ( at least on the surface ) the younger, less experienced addition received 650,000 options vs. Richard's 75,000 ... Hmmmm

People I talk to say it was simply about making the next big handout - 400,000 at .46 look more "in-line" .. I have NO opinion on such matters, but can only use historic fact to guide potential logic.

Bear in mind, the boared is "independent", so all rewards are clearly justified and well thought out.

Bear in moind II, VP Foster, perhaps our most important "hands on" insider ( contact person for TIGRIS ) was COMPLETELY "passed over" in the most recent and most egregious reward session ( rewarding in relation to performance / activity ) Furthermore, she chose to fore-go her option to purchase 166K at .30 CAD.  Hmmmmm, perhaps a situation where she is unable to accept insider rewarding?  A question to be asked at the AGM ( if questions are not excluded, as per recent "on-line "$lip-ups )

I'd stay tuned..but that is JUST me
<< Previous
Bullboard Posts
Next >>